Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abbott Laboratories (ABT) vs Carparts.Com Inc (PRTS) Price & Performance

Abbott Laboratories
Carparts.Com Inc

Price performance

Price movement over the last 24 hours

Key statistics

Abbott Laboratories vs Carparts.Com Inc — how do they compare? Abbott Laboratories trades at $95.23 (market cap $166.94B), while Carparts.Com Inc trades at $6 (market cap $49.97M). The key difference: Abbott Laboratories is far larger — about 3340.8× Carparts.Com Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Carparts.Com Inc pays none. Which is the better fit depends on your goals.

ABTPRTS
Market Cap
$166.94B$49.97M
Sector
HealthConsumer Cyclical
52-Week High
$136.62$11.40
52-Week Low
$82.57$3.88
Enterprise Value
$193.69B$64.94M
Dividend Yield
2.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abbott Laboratories

Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.

The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.

Carparts.Com Inc

CarParts.com (PRTS) trades at $6.14, down 0.65% on the day, following a recent 10:1 reverse stock split that helped it regain Nasdaq compliance. The stock shows a bearish technical signal with negative cash flow and net losses, though it has beaten earnings estimates for three consecutive quarters. Recent developments include a new $25 million credit facility and the launch of a co-branded Mastercard, signaling efforts to stabilize operations and enhance customer financing options.

Despite persistent losses and negative cash flow, PRTS maintains a low P/S ratio of 0.07 and has analyst support with 60% buy ratings. The primary risk is sustained profitability challenges amid declining revenue, but cost discipline and new financial tools may provide a path to recovery if execution improves.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Read more on ABT

About Carparts.Com Inc

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Read more on PRTS